Senator Dick Durbin @SenatorDurbin
Congress has a responsibility to respond to this important issue. The incoming CEO of Johnson & Johnson has a choice to make: will he continue the company's current efforts to avoid accountability to cancer victims, or reverse course? — PolitiTweet.org
Senate Judiciary Committee @JudiciaryDems
NEWS: In a letter to Johnson & Johnson's incoming CEO, Chair @SenatorDurbin, @SenWarren, @SenBlumenthal,… https://t.co/BBD5uTdeML